Molina Healthcare, Inc.는 경제적으로 취약한 가정과 개인을 주로 대상으로 종합적인 관리형 건강 관리 서비스를 제공합니다. 회사는 Medicaid 및 Medicare 프로그램과 같은 주요 ...
이 글은 Molina Healthcare, Inc.의 6.25% 15-JAN-2033 채권(MOH5939489 FINRA)에 대한 위험 프로필을 제공합니다. 신용 위험 평가를 위한 핵심 지표로서 담보 수준, 인플레이션 보호, 발행인 등급 등을 설명하여 투자자들이 해당 채권의 신뢰도를 판단하는 데 도움을 줍니다. 이 페이지에서는 채권에 대한 독점 애널리스트 등급에 대한 접근도 언급합니다.
Bronstein, Gewirtz & Grossman, LLC는 Molina Healthcare, Inc.(MOH)에 대해 회사 및 임원/이사들의 잠재적 기업 부정행위와 관련된 조사에 착수했습니다. 이 회사는 2025년 2월 5일 이전에 Molina 증권을 매수했고 현재도 보유 중인 투자자들에게 해당 조사에 참여할 것을 권하고 있습니다. 선임은 성공보수(컨틴전시 피) 방식으로 진행되며, 즉 투자자들은 선불 비용을 부담하지 않습니다.
Molina Healthcare(MOH)는 일리노이 HealthChoice 메디케이드 계약에서 중요한 수주 성과를 거둔 이후 Russell 스타일 지수에서 기술적 재편이 발생해 Russell 2500 지수 및 Russell 2500 Value 벤치마크로 이동했습니다. 이러한 지수 변경은 근본적인 변화라기보다 기술적인 것으로 평가되며, 핵심 투자 내러티브는 여전히 메디케이드 계약 성과, 비용 통제, 정책 안정성에 초점이 맞춰져 있습니다. 일리노이 계약은 향후 매출 전망을 높이지만, 회사의 재무 전망은 메디케이드 자금 변동 가능성에 민감하게 반응하는 상태입니다.
Molina Healthcare(MOH)는 일리노이 HealthChoice 메디케이드의 중요한 계약을 확보한 뒤 최근 여러 Russell 지수에서 재분류되었습니다. 이 글은 새 계약과 지수 변경이 Molina의 투자 내러티브 및 향후 수익에 어떤 영향을 미치는지 살펴보며, 회사가 메디케이드 계약, 비용 통제, 정책 안정성에 의존하고 있다는 점을 강조하는 한편 잠재적 하방 위험도 언급하고 공정가치 추정치를 제공합니다.
Centene Corporation의 자회사인 Meridian Health Plan of Illinois는 주의 HealthChoice Illinois 메디케이드 프로그램에 따라 2027년 1월 1일부터 2030년까지 4년 계약을 갱신하는 데 성공했다. 이번 갱신은 단기 이익을 크게 끌어올릴 것으로 예상되지는 않지만, 정부가 후원하는 의료 프로그램에 크게 의존하고 있는 Centene에 있어 프리미엄 매출을 유지하고 장기 이익 가시성을 높이는 데 핵심적이다. 회사 주가는 연초 대비 64.3% 상승하며 업계를 상회했고, 2026년 이익은 66.4% 성장할 것으로 전망된다.
이 글은 Molina Healthcare, Inc.의 6.25% 15-JAN-2033 채권(MOH5939489 FINRA)에 대한 위험 프로필을 제공합니다. 신용 위험 평가를 위한 핵심 지표로서 담보 수준, 인플레이션 보호, 발행인 등급 등을 설명하여 투자자들이 해당 채권의 신뢰도를 판단하는 데 도움을 줍니다. 이 페이지에서는 채권에 대한 독점 애널리스트 등급에 대한 접근도 언급합니다.
Bronstein, Gewirtz & Grossman, LLC는 Molina Healthcare, Inc.(MOH)에 대해 회사 및 임원/이사들의 잠재적 기업 부정행위와 관련된 조사에 착수했습니다. 이 회사는 2025년 2월 5일 이전에 Molina 증권을 매수했고 현재도 보유 중인 투자자들에게 해당 조사에 참여할 것을 권하고 있습니다. 선임은 성공보수(컨틴전시 피) 방식으로 진행되며, 즉 투자자들은 선불 비용을 부담하지 않습니다.
Molina Healthcare(MOH)는 일리노이 HealthChoice 메디케이드 계약에서 중요한 수주 성과를 거둔 이후 Russell 스타일 지수에서 기술적 재편이 발생해 Russell 2500 지수 및 Russell 2500 Value 벤치마크로 이동했습니다. 이러한 지수 변경은 근본적인 변화라기보다 기술적인 것으로 평가되며, 핵심 투자 내러티브는 여전히 메디케이드 계약 성과, 비용 통제, 정책 안정성에 초점이 맞춰져 있습니다. 일리노이 계약은 향후 매출 전망을 높이지만, 회사의 재무 전망은 메디케이드 자금 변동 가능성에 민감하게 반응하는 상태입니다.
Molina Healthcare(MOH)는 일리노이 HealthChoice 메디케이드의 중요한 계약을 확보한 뒤 최근 여러 Russell 지수에서 재분류되었습니다. 이 글은 새 계약과 지수 변경이 Molina의 투자 내러티브 및 향후 수익에 어떤 영향을 미치는지 살펴보며, 회사가 메디케이드 계약, 비용 통제, 정책 안정성에 의존하고 있다는 점을 강조하는 한편 잠재적 하방 위험도 언급하고 공정가치 추정치를 제공합니다.
Centene Corporation의 자회사인 Meridian Health Plan of Illinois는 주의 HealthChoice Illinois 메디케이드 프로그램에 따라 2027년 1월 1일부터 2030년까지 4년 계약을 갱신하는 데 성공했다. 이번 갱신은 단기 이익을 크게 끌어올릴 것으로 예상되지는 않지만, 정부가 후원하는 의료 프로그램에 크게 의존하고 있는 Centene에 있어 프리미엄 매출을 유지하고 장기 이익 가시성을 높이는 데 핵심적이다. 회사 주가는 연초 대비 64.3% 상승하며 업계를 상회했고, 2026년 이익은 66.4% 성장할 것으로 전망된다.
Barclays는 Agilon Health(AGL)에 대한 보유(Hold) 등급을 재확인하며 목표주가를 81.00달러로 설정했다. 애널리스트 Andrew Mok CFA는 헬스케어 부문을 담당하며 51.86%의 성공률을 보유하고 있다. Agilon Health에 대한 더 넓은 애널리스트 컨센서스 역시 보유(Hold)이며, 최근 회사의 분기 매출 14.2억 달러 및 순이익 2,997만 달러 실적 보고 이후 평균 목표주가는 57.15달러다.
Bronstein, Gewirtz & Grossman, LLC는 잠재적 기업 위법 행위와 관련해 Molina Healthcare, Inc.(MOH)에 대한 조사를 착수했다. 이 회사는 2025년 2월 5일 이전에 Molina 증권을 매수해 현재까지 보유하고 있는 투자자들에게 연락해 더 알아보고 조사에 도움을 달라고 권유하고 있다. 이 회사는 성공 보수(contingency fee) 기준으로 운영되며, 투자자 자본을 회수하고 기업의 책임을 보장하는 것을 목표로 한다.
RBC Capital Markets는 Molina Healthcare(MOH) 주식에 대한 목표주가를 216달러에서 248달러로 올리면서, 해당 주식에 대해 섹터 성과유지(Sector Perform) 등급을 재차 확인했다. 이번 조정은 의료 회사에 대한 애널리스트 회사의 수정된 전망을 반영한 것이다.
Molina Healthcare, a US-based managed care company, focuses on government-sponsored health insurance programs like Medicaid and Medicare. The company's stock performance is closely tied to enrollment growth, cost management, and US policy changes for these programs. Molina Healthcare competes for state contracts and aims to manage medical costs effectively while providing access to care for vulnerable populations.
Alignment Healthcare (ALHC) is leveraging AI and automation to improve Medicare Advantage economics, focusing on cost control through automated claims processing and back-office operations, as well as more effective management of high-acuity members. The company emphasizes quality plans and strong member retention to drive growth, despite facing challenges like the CMS V28 risk adjustment model and profitability issues with PPO plans. ALHC is positioned as a growth trend play due to its strategic use of technology and targeted care.
Molina Healthcare is a managed care company focused on providing health services to Medicaid and Medicare members across the United States. The company's core business involves Medicaid managed care contracts and Medicare Advantage plans, emphasizing value-based care and cost control. Investors track Molina Healthcare for its enrollment trends in government-sponsored programs, operational discipline, and ability to manage medical costs and adapt to regulatory changes.
Molina Healthcare (MOH) stock recently hit a new 52-week high at $237.96, reflecting a 34% year-to-date return despite a slight annual decline. The company also secured a significant Medicaid contract in Illinois starting in 2027 and received a "Sector Perform" rating from RBC Capital, with a price target of $216. InvestingPro analysis suggests the stock is currently undervalued.
Molina Healthcare Inc. (MOH) recently hit a 52-week high of $237.96, reflecting a 34% year-to-date return but a slight annual decline of 0.33%. Despite the recent surge, InvestingPro indicates the stock may be undervalued. The company also secured a significant Medicaid contract in Illinois and received a "Sector Perform" rating from RBC Capital, with a $216 price target.
Molina Healthcare Inc. (MOH) stock recently hit a 52-week high of $237.96, showing strong recent performance with a 34% year-to-date return despite a slight decline over the past year. The company secured a major Medicaid contract in Illinois starting in 2027 and RBC Capital initiated coverage with a "Sector Perform" rating, setting a $216 price target. Increased options trading also indicates heightened investor interest in MOH.
The Molina Healthy Advantage Silver 2470 is a Medicare Advantage plan from Molina Healthcare designed for beneficiaries seeking predictable copays and integrated benefits in specific US markets. This plan combines Medicare Parts A and B, typically D, focusing on coordinated care and fixed costs for primary and specialist visits. It's particularly relevant to investors in Molina Healthcare (NYSE: MOH) as it reflects the company's strategy in the government-sponsored health plan sector under CMS oversight.
Molina Healthcare Inc. (MOH) shares rose 2.28% to $232.90 on Tuesday, despite a general market downturn where the S&P 500 and Dow Jones Industrial Average both fell. This increase broke a two-day losing streak for the stock. The outperformance occurred during a poor trading session for the broader stock market.
Alignment Healthcare (ALHC) has shown improved profitability, higher guidance, and stronger cash flow, but its stock rally means its current price may already reflect much of this operational progress. While the company's fundamentals are improving, its current valuation is higher than its historical median, suggesting that further upside may depend on fresh estimate momentum or a more attractive entry point. Analysts offer a modest 1.5% average price target increase from the last closing price.
Molina Healthcare specializes in providing managed care services to Medicaid and Medicare beneficiaries across various U.S. states. The company's business model is deeply intertwined with government-sponsored health plans, making policy changes and enrollment trends critical factors for its investors. Its focus on public health coverage means its growth depends significantly on enrollment numbers and state-designed coverage contracts, requiring a balance between competitive bids and quality care delivery.
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims against Molina Healthcare, Inc. (MOH) for alleged corporate wrongdoing. The firm encourages investors who purchased Molina securities before February 5, 2025, and still hold them, to join the investigation. Bronstein, Gewirtz & Grossman, LLC represents investors on a contingency fee basis to recover capital and ensure corporate accountability.
Nealesh D. Shah, SVP and CFO of Kosmos Energy Ltd., sold 45,980 shares of the company's common stock for a total of $94,258 on July 2, 2026, to cover tax withholding requirements from restricted share unit vesting. This sale followed his acquisition of 118,329 shares on July 1, 2026, through vested restricted share units. Despite the sale, Shah directly holds 1,935,410 shares, and the company's stock has seen a significant surge year-to-date, although it faces profitability challenges and recent mixed analyst ratings.
Alignment Healthcare (ALHC) is attracting investor interest due to strong Medicare Advantage growth, high-quality ratings, and increasing operating leverage translating into profitability. The company reported a Q1 2026 profit and raised its full-year membership and revenue outlook, though utilization and execution risks remain. ALHC's focus on quality, retention, and automation is driving margin expansion, positioning it as a growth story with improving fundamentals despite some operational challenges.
Molina Healthcare's stock is performing well due to investor focus on the company's growth in Medicaid and Medicare memberships, disciplined margin management, and strategic capital deployment within the evolving US managed-care market. The company's business model relies on government contracts, with its success tied to efficient care management, cost control, and adaptability to regulatory changes. Investors closely monitor membership trends, operational efficiency, and capital allocation as key drivers of the company's financial performance.
This document is a transcript of Molina Healthcare's Q1 2026 earnings call, provided by Quartr. It focuses solely on the company's financial performance and discussions during the call. The content is primarily the verbatim record of the earnings presentation and Q&A.
Ambetter health plans by Centene Corp. are a major product line on the Affordable Care Act (ACA) marketplaces, providing essential health benefits to millions of US families. The plans offer tiered options (bronze, silver, gold), digital tools, and focus on affordability for individuals and families without employer-sponsored coverage. Ambetter's presence across many states and its integration with ACA subsidies make it a significant player in the national health insurance landscape, affecting both consumers and Centene's financial performance.
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Molina Healthcare, Inc. (MOH) who bought securities prior to February 5, 2025, and still hold them. The investigation focuses on whether Molina, its officers, and/or directors engaged in corporate wrongdoing. Investors are encouraged to contact the firm to assist with the investigation, which is conducted on a contingency fee basis.
This article provides financial information for Molina Healthcare Inc. (NYSE: MOH), specifically focusing on its forward price-to-earnings ratio. The content is presented within the TradingView platform and indicates that no current trades were observed at the time of access.
Molina Healthcare specializes in government-sponsored health plans, primarily focusing on Medicaid, Medicare, and Affordable Care Act (ACA) marketplaces. The company operates as a managed care organization, contracting with state agencies to provide health benefits to vulnerable populations, emphasizing care coordination and cost control. Its business model, which includes a diversified portfolio of government-related health plans, is attractive to investors interested in publicly funded healthcare.
Molina Healthcare (MOH) was recently reclassified into the Russell 2500 and Russell 2500 Value indices, moving out of growth and defensive indices. This shift reflects an emphasis on its value characteristics, though the core investment narrative remains tied to its Medicaid-centric model and managing medical costs. The reclassification and recent risk adjustment transfers highlight ongoing challenges to earnings quality, influencing its fair value and future outlook.
Molina Healthcare is a major managed care provider in the US, primarily serving individuals through government-sponsored Medicaid and Medicare Advantage programs. The company's business model relies on fixed per-member-per-month payments, making cost management and efficient medical care crucial to its financial performance. Molina Healthcare aims for long-term growth by deepening its presence in existing states and entering new markets, carefully balancing expansion with capital discipline and regulatory requirements.
This article displays the "Enterprise value to EBIT forward" for Molina Healthcare Inc. (NYSE: MOH). The content primarily consists of navigation and financial data presentation, with the specific value for the metric appearing under the "Period" and "Value" columns.
This article provides financial data for Molina Healthcare Inc (NYSE: MOH), specifically focusing on its enterprise value to revenue forward metric. The information is presented within a TradingView context, displaying details like market status, financial overview, and related data sources. The content itself seems to be a data point or a prompt for further financial analysis rather than a narrative article.
This article focuses on the "Price to sales forward" metric for Molina Healthcare Inc (NYSE: MOH). It provides a snapshot of this financial ratio sourced from TradingView, indicating specific period values and changes. The content is primarily a data presentation page from a financial platform.
This article provides financial information for Molina Healthcare, Inc. under the GETTEX:MHG ticker. It focuses specifically on the "Price to sales forward" metric, indicating a financial analysis tool provided by TradingView. The page displays the current trading status and financial details for the company.
This article provides a list of Exchange Traded Funds (ETFs) that hold Molina Healthcare, Inc. (MHG) stocks. The list is sorted by market value and includes various details such as weight, issuer, management style, expense ratio, assets under management (AUM), price, change percentage, and 3-year NAV total return. The ETFs cover different market segments like small-cap, mid-cap, large-cap, and sector-specific healthcare funds.
Molina Healthcare is focusing on its Medicaid and Medicare managed care business, which benefits from strong demand for government-sponsored health coverage in the U.S. The company's strategy emphasizes stable enrollment, disciplined cost management, and diversification through Medicare Advantage and health insurance marketplace plans. Success hinges on winning and retaining state and federal contracts, managing medical costs, and demonstrating quality outcomes.
Molina Healthcare (MOH) was recently reclassified into Russell 2500 Value indices, indicating a shift in its investor base towards value characteristics. This reclassification occurs amidst challenges such as exchange risk adjustment transfers and potential medical cost inflation, which could impact its Medicaid-focused business model. Despite these challenges, the article highlights varying analyst forecasts and encourages investors to conduct their own analysis, suggesting that the core investment narrative remains Medicaid-centric.
Molina Healthcare (MOH) was recently reclassified into Russell 2500 and Russell 2500 Value indices, moving out of growth and defensive indices. This shift highlights a focus on its value characteristics and Medicaid-centric model, despite facing headwinds from exchange risk adjustment transfers and persistent medical cost inflation. The article discusses how this reclassification and recent financial developments, including an estimated US$11.2 million additional payment for exchange risk adjustment transfers, impact Molina's investment narrative and earnings outlook, projecting a 17% downside from its current price based on fair value estimates.
Molina Healthcare director Dale B. Wolf received a quarterly equity award of 237 common shares, valued at $55,000, as part of his director compensation under the company's 2025 Equity Incentive Plan. This grant, based on the closing price of $232.55 on July 1, 2026, increased his indirect holdings to 15,633 shares held in a revocable trust. The award represents a quarter of his annual equity compensation, which totals $220,000.
Molina Healthcare director Steven J. Orlando, through the Orlando Family Trust, received a grant of 237 shares of common stock on July 1, 2026. This grant values at $55,000, part of a $220,000 annual director equity package under the company’s 2025 Equity Incentive Plan. Following this transaction, the trust holds 17,967 shares, with an additional 1,500 shares held indirectly through Orlando’s 401(k) plan.
Molina Healthcare director Richard M. Schapiro received a quarterly stock grant of 237 shares, valued at $55,000, as part of his annual $220,000 equity compensation. This grant, issued on July 1, 2026, under the company's 2025 Equity Incentive Plan, increased his direct holdings to 12,311 shares of common stock. The transaction reflects routine equity-based compensation for his board service.
Molina Healthcare director Richard C. Zoretic was granted 237 shares of common stock, valued at $55,000, as part of his board service compensation. This grant, under the company's 2025 Equity Incentive Plan, represents a quarterly portion of a $220,000 annual equity package, calculated based on the stock's closing price of $232.55 per share on July 1, 2026. After this transaction, Zoretic indirectly holds 9,389 shares through his revocable living trust.
Molina Healthcare director Ronna Romney's revocable trust received a quarterly stock grant of 237 shares, valued at $55,000. This award is part of her annual $220,000 equity compensation under the 2025 Equity Incentive Plan, based on the stock's closing price of $232.55 on July 1, 2026. Following this transaction, her trust indirectly holds 17,869 Molina Healthcare shares.
Investing.com published a report titled "Form 4 Molina Healthcare Inc For: 2 July," noting that Molina Healthcare's stock (MOH) experienced a -1.25% change. The article primarily functions as a placeholder for a financial filing and includes various market data and other news headlines.
Molina Healthcare director Leo P. Grohowski received a quarterly stock grant of 237 shares of common stock, valued at $55,000, on July 1, 2026. This grant, part of the company's 2025 Equity Incentive Plan, compensates him for his board service. Following this transaction, Grohowski directly holds 1,542 shares of Molina Healthcare common stock.
Molina Healthcare director Francis S. Soistman Jr. received a grant of 237 shares of common stock valued at $55,000 on July 1, 2026, as part of his director compensation under the company's 2025 Equity Incentive Plan. This quarterly award is based on an annual equity award of $220,000, and the shares were granted at a closing price of $232.55 per share. Following this transaction, Soistman directly holds 907 shares of Molina Healthcare common stock.
Molina Healthcare's Chief Operating Officer, James Woys, acquired 144 shares of common stock through the company's 2019 Employee Stock Purchase Plan (ESPP) at a price of $147.51 per share. This purchase represents 85% of the lower closing price during the offering period. Following this transaction, Woys directly holds 90,178 shares of Molina Healthcare common stock.
Molina Healthcare EVP Debra Bacon recently reported insider transactions, including the acquisition of 23 shares through the Employee Stock Purchase Plan (ESPP) on June 30, 2026. On July 1, 2026, she surrendered 183 shares to cover withholding taxes related to the vesting of 529 shares. Following these transactions, Bacon directly holds 21,636 Molina Healthcare shares, with additional restricted shares scheduled to vest in 2027, 2028, and 2029.
Molina Healthcare's Chief Legal Officer, Jeff D. Barlow, acquired 138 shares of company common stock on June 30, 2026, through the 2019 Employee Stock Purchase Plan at a price of $147.51 per share. This transaction increases his direct holdings to 67,313 shares. The purchase price was determined based on 85% of the lower closing price, with a reference price of $173.54.
Molina Healthcare Inc. (MOH) shares dropped by 1.15% to $229.87, on a mixed day for the broader market. Despite this daily loss, the stock closed 14.28% below its 52-week high, indicating strong performance relative to its peak. The S&P 500 remained largely unchanged, while the Dow Jones Industrial Average saw a gain.
Molina Healthcare, a US-based managed care company, specializes in providing health insurance services through government programs like Medicaid and Medicare. The company's growth and profitability are closely tied to enrollment levels, effective management of medical costs relative to fixed payments, and the ever-changing policy environment surrounding public health coverage. Investors closely monitor these factors, along with regulatory developments and industry performance, to assess Molina Healthcare's financial health and future prospects.
